HLB Panagene Co Ltd
046210
Company Profile
Business description
HLB Panagene Co Ltd is a South Korea-based company that operates as a specialized bio venture company. The group is developing various technologies and products utilizing PNA (Peptide Nucleic Acid), an artificial gene.
Contact
54 Techno 10-ro
Yuseong-gu
Daejeon
KORT: +82 428619295
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
83
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,059.70 | 23.70 | -0.26% |
| CAC 40 | 8,103.85 | 17.22 | -0.21% |
| DAX 40 | 24,340.06 | 56.09 | 0.23% |
| Dow JONES (US) | 48,442.41 | 79.73 | 0.16% |
| FTSE 100 | 9,889.22 | 23.25 | 0.24% |
| HKSE | 25,774.14 | 27.63 | -0.11% |
| NASDAQ | 23,561.84 | 133.02 | 0.57% |
| Nikkei 225 | 50,477.24 | 64.37 | 0.13% |
| NZX 50 Index | 13,543.53 | 25.80 | 0.19% |
| S&P 500 | 6,909.79 | 31.30 | 0.46% |
| S&P/ASX 200 | 8,758.30 | 25.50 | -0.29% |
| SSE Composite Index | 3,919.98 | 2.61 | 0.07% |